T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an Anti-Inflammatory diet tame type 2 diabetes?
Disease control Recruiting nowThis study tests whether a special anti-inflammatory diet can lower inflammation and improve blood sugar control in people with type 2 diabetes. 88 adults will be randomly assigned to either the anti-inflammatory diet or standard diabetes dietary advice for 4 weeks. Researchers w…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to reverse fatty liver damage in diabetics
Disease control Recruiting nowThis study tests whether a drug called chiglitazar, combined with anti-inflammatory and liver-protecting therapies, can improve liver health in people who have both MASH (a severe fatty liver disease) and type 2 diabetes. About 300 adults will receive either the drug combo or a p…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a fitbit and AI texts get sedentary diabetes patients moving?
Disease control Recruiting nowThis study is testing whether giving people with type 2 diabetes a Fitbit and sending them personalized text messages from an AI chatbot can help them become more active and improve their health. Thirty-six sedentary adults will wear the Fitbit daily for 12 weeks and receive week…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Diabetes drug semaglutide may fight inflammation and protect blood vessels
Disease control Recruiting nowThis phase 4 trial tests whether adding semaglutide to standard diabetes treatment reduces inflammation and improves blood vessel health in 80 people with type 2 diabetes who have no heart disease. Participants receive either semaglutide injections plus standard care or standard …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New triple therapy aims to tame tough diabetes
Disease control Recruiting nowThis study tests a combination of three diabetes drugs (metformin, SGLT-2 inhibitor, and GLP-1 receptor agonist) versus other oral medications in adults with type 2 diabetes who have poor blood sugar control. The goal is to see which combo works better at lowering blood sugar, bl…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a smart food program plus glucose tracking transform diabetes care?
Disease control Recruiting nowThis study tests whether adding a continuous glucose monitor (CGM) and nutrition counseling to a food-as-medicine program helps adults with type 2 diabetes and food insecurity better manage their blood sugar. Sixty participants will be split into two groups: one gets the standard…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC